Alstrom syndrome screening

	Alstrom syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Differentiating Alstrom syndrome from other Diseases
Epidemiology and Demographics
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Tertiary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Alstrom syndrome screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
slides
Images
American Roentgen Ray Society Images of Alstrom syndrome screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Alstrom syndrome screening
CDC on Alstrom syndrome screening
Alstrom syndrome screening in the news
Blogs on Alstrom syndrome screening
Directions to Hospitals Treating Alstrom syndrome
Risk calculators and risk factors for Alstrom syndrome screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]

Screening

Fasting glucose levels are evaluated every two to three months. Closer follow-up is needed if fasting or postprandial blood glucose concentrations are elevated.

Twice-yearly urinalysis and plasma concentrations of electrolytes, uric acid, BUN, and creatinine.
Annual assessment of vision and hearing; weight, height, and body mass index; heart (including echocardiography); plasma insulin concentration; lipid profile; plasma ALT, AST, and GGT concentrations; pulmonary function; thyroid function.
Every one to two years, renal and bladder ultrasound examinations if symptomatic and/or if urinalysis is abnormal.